Savara (SVRA) Gains from Investment Securities (2010 - 2026)

Savara (SVRA) reported Gains from Investment Securities of $12.9 million for Q1 2026, up 17045.9% year-over-year from N/an in Q1 2025, and down 2.79% quarter-over-quarter from $13.2 million in Q4 2025.

Savara (SVRA) Gains from Investment Securities (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Gains from Investment Securities data on file, last reported at $12.9 million in Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at $12.9 million, up 17045.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (up 17045.9% YoY), and the FY2025 annual result was $13.2 million, down 2.3% from the prior year.
  • Gains from Investment Securities fell to $12.9 million in Q1 2026 per SVRA's latest filing, from $13.2 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $13.6 million in Q4 2024 and troughed at $381.0 in Q1 2024.
  • A 5-year average of $4.2 million and a median of $35718.0 in 2025 frame the typical range for Gains from Investment Securities.
  • The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities slumped 99.99% in 2022, then jumped 59909.41% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $7.9 million in 2022, then advanced by 21.43% to $9.6 million in 2023, then soared by 40.71% to $13.6 million in 2024, then slipped by 2.3% to $13.2 million in 2025, then dropped by 2.79% to $12.9 million in 2026.
  • Business Quant data shows SVRA's Gains from Investment Securities at $12.9 million in Q1 2026, $13.2 million in Q4 2025, and $13.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Savara 1.39 Bn 1.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 12.87 Mn
Mar 31, 2026 12.87 Mn
Dec 31, 2025 13.24 Mn
Dec 31, 2025 13.24 Mn
Sep 30, 2025 13.21 Mn
Sep 30, 2025 13.21 Mn
Jun 30, 2025 35,718.00
Jun 30, 2025 35,718.00
Mar 31, 2025 75,083.00
Mar 31, 2025 75,083.00
Dec 31, 2024 13.55 Mn
Dec 31, 2024 13.55 Mn
Sep 30, 2024 22,013.00
Sep 30, 2024 22,013.00
Jun 30, 2024 381.00
Jun 30, 2024 381.00
Mar 31, 2024 381.00
Mar 31, 2024 381.00
Dec 31, 2023 9.63 Mn
Dec 31, 2023 9.63 Mn